Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa (Q42909682)

10 November 2017

title

Towards the complete eradication of mother-to-child HIV/HBV coinfection at Saint Camille Medical Centre in Burkina Faso, Africa (English)

1 reference

eradication of infectious diseases

10 November 2017

0 references

1 reference

8

Virginio Pietra

1 reference

10 November 2017

Jacques Simpore

2

0 references

Cyrille Bisseye

series ordinal

4

object named as

Cyrille Bisseye

1 reference

10 November 2017

3

Djeneba Ouermi

1 reference

10 November 2017

5

Tani Sagna

1 reference

10 November 2017

10

Charlemagne Gnoula

1 reference

10 November 2017

Jean-Baptiste Nikiema

series ordinal

11

object named as

Jean-Baptiste Nikiema

1 reference

10 November 2017

6

Silvia Odolini

1 reference

10 November 2017

1

Denise Ilboudo

1 reference

10 November 2017

12

Salvatore Musumeci

1 reference

10 November 2017

Fabio Buelli

7

1 reference

10 November 2017

Salvatore Pignatelli

series ordinal

9

1 reference

10 November 2017

language of work or name

1 reference

1 May 2010

1 reference

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

10 November 2017

published in

1 reference

10 November 2017

volume

14

1 reference

10 November 2017

issue

3

1 reference

10 November 2017

page(s)

219-224

1 reference

Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso

10 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Hepatitis viruses: mother to child transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Maternofetal transmission of hepatitis B virus genotype E in Ghana, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Prevalence of Human Herpes Virus-8 and Hepatitis B Virus among HIV Seropositive Pregnant Women Enrolled in the Mother-to-child HIV Transmission Prevention Program at Saint Camille Medical Centre in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Hepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

[Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Toxoplasma gondii, HCV, and HBV seroprevalence and co-infection among HIV-positive and -negative pregnant women in Burkina Faso

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Prevention of mother-to-child transmission of HIV in Haiti

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Prevalence and risk factors for HIV, syphilis, hepatitis B, hepatitis C, and HTLV-I/II infection in low-income postpartum and pregnant women in Greater Metropolitan Vitória, Espírito Santo State, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

Decreasing incidence of hepatocellular carcinoma among children following universal hepatitis B immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1413-8670%2810%2970047-7

7 January 2021

10.1016/S1413-8670(10)70047-7

Identifiers

DOI

1 reference

10 November 2017

1 reference